Skip to main content
Premium Trial:

Request an Annual Quote

… and Promega Facility Obtains ISO 13485 Certification

NEW YORK (GenomeWeb News) – Promega today said its Madison, Wis.-based R&D and manufacturing campus has obtained ISO 13485 certification.
 
According to Promega, the standard “is recognized as the global quality standard for the development, manufacture, testing and delivery of medical devices.”
 
Promega has been certified under the ISO'S 9001 standard since 1998, the company said.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.